Generali Asset Management SPA SGR Buys 2,983 Shares of Intuitive Surgical, Inc. $ISRG

Generali Asset Management SPA SGR boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 22,212 shares of the medical equipment provider’s stock after buying an additional 2,983 shares during the period. Generali Asset Management SPA SGR’s holdings in Intuitive Surgical were worth $9,032,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of ISRG. Jacobsen Capital Management lifted its holdings in shares of Intuitive Surgical by 5.1% in the 3rd quarter. Jacobsen Capital Management now owns 634 shares of the medical equipment provider’s stock worth $258,000 after acquiring an additional 31 shares during the last quarter. Asset Management One Co. Ltd. increased its holdings in Intuitive Surgical by 0.3% in the 3rd quarter. Asset Management One Co. Ltd. now owns 194,842 shares of the medical equipment provider’s stock valued at $79,229,000 after purchasing an additional 624 shares during the last quarter. John Boyer Inc. acquired a new stake in Intuitive Surgical in the 3rd quarter valued at approximately $27,000. Latitude Advisors LLC purchased a new stake in Intuitive Surgical in the third quarter valued at approximately $122,000. Finally, SYM FINANCIAL Corp purchased a new stake in Intuitive Surgical in the third quarter valued at approximately $280,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In related news, Director Craig H. Barratt sold 1,150 shares of Intuitive Surgical stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $443.80, for a total value of $510,370.00. Following the completion of the transaction, the director owned 1,150 shares in the company, valued at $510,370. The trade was a 50.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 20,095 shares of the business’s stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $451.61, for a total transaction of $9,075,102.95. Following the transaction, the director owned 1,204,530 shares of the company’s stock, valued at $543,977,793.30. This trade represents a 1.64% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 38,806 shares of company stock valued at $16,824,795. 0.60% of the stock is owned by corporate insiders.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Wall Street remains broadly bullish on ISRG. The consensus rating is “Moderate Buy,” with an average price target of $493.54, while Zacks recently upgraded the stock to “Strong Buy.” Raymond James and BTIG also reiterated positive ratings. Wall Street Views on Intuitive Surgical
• Positive Sentiment: Intuitive Surgical’s latest quarter showed solid demand: revenue rose 21.7% year over year to $3.05 billion, exceeding estimates, while earnings of $3.00 per share beat the $2.65 consensus. This supports the long-term growth case for its da Vinci robotic-surgery business. Intuitive Surgical Earnings and Valuation
• Neutral Sentiment: Recent performance has been mixed: the stock has rebounded over the past one to three months, but remains below its prior-year level. Investors are assessing whether continued procedure growth and higher estimates can justify ISRG’s premium valuation.
• Negative Sentiment: Several insiders reported stock sales, including EVP Mark Brosius, SVP Patricia Wadors, former CEO Gary Guthart and insider Fredrik Widman. Brosius sold shares in two transactions, while Guthart’s reported sale was approximately $9.1 million. The trades were made under pre-arranged Rule 10b5-1 plans, reducing their signaling value, but the volume of selling may weigh on sentiment. Gary Guthart Insider Sale
• Negative Sentiment: Despite the earnings beat, lower net income and earnings-per-share comparisons have highlighted margin pressure. With ISRG trading at a high earnings multiple, investors may be particularly sensitive to any slowdown in profitability or procedure growth. Why Intuitive Surgical’s Strong Quarter Spooked Investors

Wall Street Analysts Forecast Growth

A number of research firms have commented on ISRG. KeyCorp restated an “overweight” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $450.00 to $475.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 21st. Zacks Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 22nd. Sanford C. Bernstein reiterated an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Finally, HSBC downgraded Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price objective on the stock. in a report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $493.54.

Intuitive Surgical Price Performance

ISRG stock opened at $444.18 on Thursday. The firm has a market capitalization of $153.97 billion, a P/E ratio of 53.71, a P/E/G ratio of 3.12 and a beta of 1.46. The business’s 50-day moving average is $399.37 and its two-hundred day moving average is $435.44. Intuitive Surgical, Inc. has a 1 year low of $328.57 and a 1 year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The business had revenue of $3.05 billion during the quarter, compared to analysts’ expectations of $2.91 billion. During the same quarter last year, the business posted $2.40 EPS. The business’s quarterly revenue was up 21.7% compared to the same quarter last year. On average, analysts expect that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.